Skip to content

Kira Specialist

For Your Health

  • Contact Us

Category: Reproductive system cancer drugs

4 Posts
Nov 19, 2022

Pamiparib Pamiparib

Reproductive system cancer drugs

Formulation and Specifications: Capsules: 20 mgIndications: Pamiparib is indicated for the treatment of patients with recurrent advanced ovarian, fallopian tube, or primary peritoneal cancer with germline BRCA mutations who have…

Read More Read More by Specialist
Nov 19, 2022

Fluzoparib Fluzoparib

Reproductive system cancer drugs

Formulation and specifications: Capsules: 50mgIndications:1. Maintenance therapy for adult patients with platinum-sensitive recurrent epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer after achieving complete remission or partial remission…

Read More Read More by Specialist
Nov 19, 2022

Niraparib Niraparib

Reproductive system cancer drugs

Formulation and Specifications: Capsules: 100mgIndications:1. This product is indicated for the maintenance treatment of adult patients with advanced epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer after achieving…

Read More Read More by Specialist
Nov 19, 2022

Olaparib Olaparib

Reproductive system cancer drugs

Formulation and specifications: Tablets: 100mg, 150mgIndications:1. Maintenance therapy for adult patients carrying germline or somatic BRCA mutations in advanced epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer in…

Read More Read More by Specialist

Search

Reproductive system cancer drugs

  • Pamiparib Pamiparib
  • Fluzoparib Fluzoparib
  • Niraparib Niraparib
  • Olaparib Olaparib
Copyright KiraSpecialist